We are a Highly experienced

Health Economics & Outcomes Research (HEOR) Agency

What we do

We identify, evaluate and communicate the value of drugs and devices

Evidence development

Evidence Development

Systematic literature reviews

Rapid and pragmatic literature reviews

Strategic evidence searches

Environmental scans

Health economics

Health Economic Modelling

Early-stage economic evaluations

Global cost-effectiveness models

Local country adaptations

Budget impact models


Health Technology Assessment

Reimbursement submissions

Advisory board management

Reimbursement Strategy

Statistical analysis

Statistical Analysis

Network meta-analysis

Matching-adjusted indirect comparison

Trial data analysis

Survival analysis

Medical Writing

Strategic publication planning

Manuscripts for peer review 

Poster design and production

Podium presentations

Training & Workshops

Online courses

Client site management training

Client site technical training

Bespoke workshops



What makes us different

We are a small group of highly experienced researchers with international backgrounds in academia, government and industry. Our deep knowledge and nimble approach allows us to meet your needs with flexibility, technical excellence, timeliness and good humour. We take pride in our work and we get results. We are experts in achieving reimbursement for pharmaceuticals and devices in countries around the world, and communicating value in healthcare to diverse audiences.

rigorous solutions for complex problems

Years in business

From Our Clients

"I have worked with Symmetron on HTAs for NICE and SMC and found the team professional, flexible in responding to my needs and willing to go the extra mile to deliver on our desired outcomes. I look forward to working with them again."

Director of Market Access & External Affairs

LEO Pharma UK

"Symmetron has led the development of several complex economic models for us over several years and has always delivered rigorous research and rock-solid timely results. All output always stood up to HTA scrutiny and what I admired most is how well Symmetron managed not only the development of the model, but also the KOL alignment meetings. A tremendous pleasure to work with and a relaxing experience."

Director of Global Health Economics and Outcomes Research

Medical Device Company